Related Experiment Videos
Summary
Prenatal diagnosis of propionic acidemia is now possible by detecting methylcitrate in amniotic fluid. This rapid method confirms the diagnosis through enzyme analysis, ensuring healthy births.
Area of Science:
- Biochemistry
- Medical Genetics
- Metabolic Disorders
Background:
- Propionic acidemia is a serious inherited metabolic disorder.
- Accurate and timely prenatal diagnosis is crucial for management.
- Existing diagnostic methods can be time-consuming.
Purpose of the Study:
- To establish a rapid prenatal diagnostic method for propionic acidemia.
- To identify a unique biomarker for prenatal detection.
- To confirm the diagnosis using enzyme activity assays.
Main Methods:
- Detection of methylcitrate in amniotic fluid using liquid partition chromatography and gas chromatography-mass spectrometry.
- Assay of propionyl-CoA carboxylase activity in cultured amniotic fluid cells and fetal tissues.
- Analysis of organic acids in amniotic fluid.
Main Results:
- Methylcitrate was detected in the amniotic fluid of a fetus with propionic acidemia.
- Deficient propionyl-CoA carboxylase activity confirmed the diagnosis.
- Absence of methylcitrate in subsequent pregnancies predicted normal or heterozygous outcomes.
- Rapid diagnosis was achieved within 48 hours of sample collection.
Conclusions:
- Detection of methylcitrate in amniotic fluid is a reliable method for prenatal diagnosis of propionic acidemia.
- This approach allows for rapid and accurate prenatal testing.
- The method may be applicable to other metabolic disorders with unique biomarkers.